Elicio Therapeutics Inc
NASDAQ:ELTX
Cash Flow Statement
Cash Flow Statement
Elicio Therapeutics Inc
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(67)
|
(80)
|
(117)
|
(100)
|
(98)
|
(55)
|
(32)
|
(24)
|
(17)
|
(39)
|
(29)
|
(31)
|
(33)
|
(35)
|
(42)
|
(39)
|
(47)
|
(52)
|
(51)
|
(55)
|
(46)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
|
| Stock-Based Compensation |
0
|
0
|
7
|
8
|
10
|
1
|
(4)
|
(6)
|
(6)
|
1
|
1
|
(0)
|
(2)
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
19
|
31
|
53
|
49
|
42
|
28
|
6
|
6
|
3
|
4
|
5
|
4
|
5
|
2
|
3
|
0
|
9
|
11
|
10
|
15
|
9
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
26
|
28
|
27
|
39
|
(26)
|
(30)
|
(37)
|
(34)
|
(4)
|
(7)
|
(4)
|
0
|
(0)
|
2
|
2
|
(1)
|
4
|
6
|
5
|
(1)
|
|
| Cash from Operating Activities |
(48)
N/A
|
(23)
+52%
|
(35)
-55%
|
(24)
+31%
|
(18)
+28%
|
(53)
-198%
|
(56)
-6%
|
(55)
+1%
|
(48)
+12%
|
(38)
+21%
|
(31)
+20%
|
(30)
+1%
|
(27)
+11%
|
(33)
-20%
|
(37)
-12%
|
(36)
+1%
|
(38)
-6%
|
(37)
+3%
|
(35)
+5%
|
(35)
+0%
|
(39)
-11%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+33%
|
(0)
-100%
|
(0)
-275%
|
(0)
-20%
|
(0)
-6%
|
(0)
+11%
|
(0)
+74%
|
(0)
+67%
|
0
N/A
|
(10)
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-7%
|
10
N/A
|
(0)
N/A
|
(0)
+50%
|
(0)
-105%
|
(0)
N/A
|
(0)
+48%
|
(0)
-2%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
20
|
21
|
132
|
126
|
113
|
(1)
|
(112)
|
(112)
|
(113)
|
0
|
0
|
(0)
|
(0)
|
7
|
18
|
18
|
30
|
23
|
13
|
15
|
22
|
|
| Net Issuance of Debt |
37
|
32
|
32
|
17
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
10
|
10
|
10
|
10
|
0
|
20
|
20
|
29
|
39
|
10
|
|
| Other |
0
|
(1)
|
(3)
|
(6)
|
(6)
|
108
|
110
|
113
|
113
|
0
|
(3)
|
22
|
22
|
22
|
0
|
(0)
|
(1)
|
(1)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
57
N/A
|
52
-8%
|
161
+207%
|
137
-15%
|
107
-22%
|
107
+0%
|
(1)
N/A
|
1
N/A
|
0
-67%
|
(0)
N/A
|
(3)
-5 433%
|
32
N/A
|
32
+0%
|
39
+22%
|
53
+37%
|
18
-66%
|
49
+172%
|
42
-14%
|
42
-2%
|
54
+29%
|
32
-40%
|
|
| Change in Cash | ||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
9
N/A
|
29
+224%
|
125
+330%
|
112
-10%
|
89
-21%
|
54
-39%
|
(57)
N/A
|
(54)
+6%
|
(48)
+12%
|
(38)
+20%
|
(44)
-14%
|
1
N/A
|
4
+285%
|
6
+43%
|
26
+346%
|
(18)
N/A
|
11
N/A
|
5
-52%
|
6
+24%
|
19
+189%
|
(7)
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(48)
N/A
|
(23)
+52%
|
(36)
-55%
|
(25)
+30%
|
(18)
+27%
|
(53)
-194%
|
(56)
-6%
|
(55)
+2%
|
(48)
+12%
|
(38)
+21%
|
(31)
+20%
|
(30)
+1%
|
(27)
+10%
|
(33)
-20%
|
(37)
-12%
|
(36)
+1%
|
(38)
-6%
|
(37)
+3%
|
(35)
+5%
|
(35)
+0%
|
(39)
-11%
|
|